Literature DB >> 26365089

Quality of life in osteogenesis imperfecta: A mixed-methods systematic review.

N Dahan-Oliel1,2, S Oliel1,2, A Tsimicalis1,3, K Montpetit1, F Rauch1,4, M J Dogba5.   

Abstract

Clinical interventions and research have mostly focused on the orthopedic, genetic, and pharmacological outcomes of individuals with osteogenesis imperfecta (OI), and although quality of life (QoL) has gained recognition as an important patient-outcome, it has received little attention in individuals with OI. This mixed-methods systematic review of the literature included five search engines and identified a total of 212 articles. Once study eligibility was reviewed, 10 studies met the inclusion criteria and were included in this mixed-methods review (9 quantitative and 1 qualitative). Among the 10 included QoL studies, six reported on children with OI, three on adults with OI, and one on the parents of children with OI. Physical QoL in children and adults with OI appears to be less than that of the general population, with individuals with more severe OI types reporting worse QoL. On the other hand, mental and psychosocial QoL is the same or better in individuals with OI than that of the general population. Pain, scoliosis activity limitations and participation restrictions due to decreased function are associated with lower levels of physical QoL. Researchers must agree on a definition of QoL as it relates to OI and use validated measures appropriate for evaluating QoL in OI. Pediatric studies should consider both the child and the parent's QOL perceptions as these may differ. QoL in the adult population should not be dismissed in order to offer proper client-centered interventions throughout the lifespan.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  adult; child; knowledge synthesis; mixed-methods; osteogenesis imperfecta; quality of life; systematic review; well-being

Mesh:

Year:  2015        PMID: 26365089     DOI: 10.1002/ajmg.a.37377

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  26 in total

1.  Health-related quality of life in children with osteogenesis imperfecta: a large-sample study.

Authors:  Y Song; D Zhao; L Li; F Lv; O Wang; Y Jiang; W Xia; X Xing; M Li
Journal:  Osteoporos Int       Date:  2018-12-19       Impact factor: 4.507

Review 2.  The psychosocial experience of individuals living with osteogenesis imperfecta: a mixed-methods systematic review.

Authors:  Argerie Tsimicalis; Gabrielle Denis-Larocque; Alisha Michalovic; Carolann Lepage; Karl Williams; Tian-Ran Yao; Telma Palomo; Noemi Dahan-Oliel; Sylvie Le May; Frank Rauch
Journal:  Qual Life Res       Date:  2016-02-19       Impact factor: 4.147

3.  Combined technique of titanium telescopic rods and external fixation in osteogenesis imperfecta patients: First 12 consecutive cases.

Authors:  Dmitry Popkov; Tamara Dolganova; Eduard Mingazov; Dmitry Dolganov; Andrey Kobyzev
Journal:  J Orthop       Date:  2020-06-20

4.  Investigating the psychometric properties of the EQ-5D-Y-3L, EQ-5D-Y-5L, CHU-9D, and PedsQL in children and adolescents with osteogenesis imperfecta.

Authors:  Richard Huan Xu; Liling Zhu; Rongjia Sun; Rachel Lee-Yin Tan; Nan Luo; Sainan Zou; Dong Dong
Journal:  Eur J Pediatr       Date:  2022-09-26       Impact factor: 3.860

5.  Patient-reported outcomes in a Chinese cohort of osteogenesis imperfecta unveil psycho-physical stratifications associated with clinical manifestations.

Authors:  Peikai Chen; Zhijia Tan; Anmei Qiu; Shijie Yin; Yapeng Zhou; Zhongxin Dong; Yan Qiu; Jichun Xu; Kangsen Li; Lina Dong; Hiu Tung Shek; Jingwen Liu; Eric H K Yeung; Bo Gao; Kenneth Man Chee Cheung; Michael Kai-Tsun To
Journal:  Orphanet J Rare Dis       Date:  2022-06-28       Impact factor: 4.303

6.  Pain and quality of life of children and adolescents with osteogenesis imperfecta over a bisphosphonate treatment cycle.

Authors:  Argerie Tsimicalis; Madalina Boitor; Catherine E Ferland; Frank Rauch; Sylvie Le May; Jaimie Isabel Carrier; Tracy Ngheim; Claudette Bilodeau
Journal:  Eur J Pediatr       Date:  2018-04-11       Impact factor: 3.183

7.  Combination therapy in the Col1a2G610C mouse model of Osteogenesis Imperfecta reveals an additive effect of enhancing LRP5 signaling and inhibiting TGFβ signaling on trabecular bone but not on cortical bone.

Authors:  Shannon Kaupp; Dan J Horan; Kyung-Eun Lim; Henry A Feldman; Alexander G Robling; Matthew L Warman; Christina M Jacobsen
Journal:  Bone       Date:  2019-10-21       Impact factor: 4.398

Review 8.  Pain Phenotypes in Rare Musculoskeletal and Neuromuscular Diseases.

Authors:  Anthony Tucker-Bartley; Jordan Lemme; Andrea Gomez-Morad; Nehal Shah; Miranda Veliu; Frank Birklein; Claudia Storz; Seward Rutkove; David Kronn; Alison M Boyce; Eduard Kraft; Jaymin Upadhyay
Journal:  Neurosci Biobehav Rev       Date:  2021-02-10       Impact factor: 9.052

9.  Fatigue and disturbances of sleep in patients with osteogenesis imperfecta - a cross-sectional questionnaire study.

Authors:  Heidi Arponen; Janna Waltimo-Sirén; Helena Valta; Outi Mäkitie
Journal:  BMC Musculoskelet Disord       Date:  2018-01-08       Impact factor: 2.362

10.  Use of flexible intramedullary nailing in combination with an external fixator for a postoperative defect and pseudarthrosis of femur in a girl with osteogenesis imperfecta type VIII: a case report.

Authors:  Dmitry Popkov
Journal:  Strategies Trauma Limb Reconstr       Date:  2018-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.